title: Reply.
authors.affiliation: Meander Medical Center, Amersfoort, The Netherlands.
authors.forename: Bindia
authors.initials: B
authors.lastname: Jharap
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, New York, New York.
authors.forename: Jean-Frederic
authors.initials: JF
authors.lastname: Colombel
authors.affiliation: University of California, San Diego, San Diego, California.
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects*; D063868:Patient Outcome Assessment; D014945:Wound Healing
chemical_list: D000893:Anti-Inflammatory Agents; D000068879:Adalimumab